DE69730725D1 - Synthetische phosphopeptide zur behandlung von knochenerkrankheiten - Google Patents

Synthetische phosphopeptide zur behandlung von knochenerkrankheiten

Info

Publication number
DE69730725D1
DE69730725D1 DE69730725T DE69730725T DE69730725D1 DE 69730725 D1 DE69730725 D1 DE 69730725D1 DE 69730725 T DE69730725 T DE 69730725T DE 69730725 T DE69730725 T DE 69730725T DE 69730725 D1 DE69730725 D1 DE 69730725D1
Authority
DE
Germany
Prior art keywords
treatment
bone diseases
phosphopeptides
synthetic phosphopeptides
synthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69730725T
Other languages
English (en)
Other versions
DE69730725T2 (de
Inventor
Yoshinari Kumagai
Akira Otaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Big Bear Bio Inc
Original Assignee
Big Bear Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Big Bear Bio Inc filed Critical Big Bear Bio Inc
Publication of DE69730725D1 publication Critical patent/DE69730725D1/de
Application granted granted Critical
Publication of DE69730725T2 publication Critical patent/DE69730725T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/16—Phosphorus containing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE69730725T 1996-07-03 1997-06-30 Synthetische Phosphopeptide zur Behandlung von Knochenerkrankungen Expired - Fee Related DE69730725T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/675,031 US5837674A (en) 1996-07-03 1996-07-03 Phosphopeptides and methods of treating bone diseases
US675031 1996-07-03
PCT/US1997/011426 WO1998000156A1 (en) 1996-07-03 1997-06-30 Synthetic phosphopeptides for treating bone diseases

Publications (2)

Publication Number Publication Date
DE69730725D1 true DE69730725D1 (de) 2004-10-21
DE69730725T2 DE69730725T2 (de) 2006-02-23

Family

ID=24708791

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69730725T Expired - Fee Related DE69730725T2 (de) 1996-07-03 1997-06-30 Synthetische Phosphopeptide zur Behandlung von Knochenerkrankungen

Country Status (11)

Country Link
US (2) US5837674A (de)
EP (1) EP0938326B1 (de)
JP (2) JP2001503452A (de)
AT (1) ATE275961T1 (de)
AU (1) AU727675B2 (de)
CA (1) CA2258661C (de)
DE (1) DE69730725T2 (de)
DK (1) DK0938326T3 (de)
ES (1) ES2224260T3 (de)
PT (1) PT938326E (de)
WO (1) WO1998000156A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837674A (en) * 1996-07-03 1998-11-17 Big Bear Bio, Inc. Phosphopeptides and methods of treating bone diseases
US20030118572A1 (en) * 1997-12-29 2003-06-26 Novozymes A/S Modified enzymes
US6818745B1 (en) * 1998-05-18 2004-11-16 University College London Polypeptide hormone phosphatonin
US7022522B2 (en) 1998-11-13 2006-04-04 Limin Guan Macroporous polymer scaffold containing calcium phosphate particles
AU782304B2 (en) * 1999-09-02 2005-07-14 Acologix, Inc. Methods and compositions for reducing serum phosphate levels
US6911425B2 (en) * 2000-08-16 2005-06-28 Acologix, Inc. Integrin binding motif containing peptides and methods of treating skeletal diseases
PT1313440E (pt) * 2000-08-16 2008-10-22 Acologix Inc Produtos dentífricos que contêm um péptido que potencia o crescimento dos ossos
US6904123B2 (en) 2000-08-29 2005-06-07 Imaging Therapeutics, Inc. Methods and devices for quantitative analysis of x-ray images
US7545964B2 (en) 2000-08-29 2009-06-09 Imaging Therapeutics, Inc. Methods and devices for quantitative analysis of x-ray images
US7467892B2 (en) 2000-08-29 2008-12-23 Imaging Therapeutics, Inc. Calibration devices and methods of use thereof
US7660453B2 (en) 2000-10-11 2010-02-09 Imaging Therapeutics, Inc. Methods and devices for analysis of x-ray images
US8639009B2 (en) 2000-10-11 2014-01-28 Imatx, Inc. Methods and devices for evaluating and treating a bone condition based on x-ray image analysis
AU2002256390B2 (en) * 2001-04-30 2007-08-30 City Of Hope Chimeric immunoreceptor useful in treating human cancers
CA2446296A1 (en) 2001-05-25 2002-12-05 Imaging Therapeutics, Inc. Methods to diagnose treat and prevent bone loss
EP1504033A2 (de) * 2002-05-03 2005-02-09 Millenium Biologix Inc. Bindegewebe stimulierende peptide
US8965075B2 (en) * 2002-09-16 2015-02-24 Imatx, Inc. System and method for predicting future fractures
US8600124B2 (en) 2004-09-16 2013-12-03 Imatx, Inc. System and method of predicting future fractures
US7840247B2 (en) * 2002-09-16 2010-11-23 Imatx, Inc. Methods of predicting musculoskeletal disease
US7220406B2 (en) * 2002-10-22 2007-05-22 Genzyme Corporation Method for promoting bone formation
JP2007524438A (ja) 2003-03-25 2007-08-30 イメージング セラピューティクス，インコーポレーテッド 放射線画像処理技術における補償の方法
CA2539487A1 (en) * 2003-09-19 2005-03-31 Imaging Therapeutics, Inc. Method for bone structure prognosis and simulated bone remodeling
US8290564B2 (en) 2003-09-19 2012-10-16 Imatx, Inc. Method for bone structure prognosis and simulated bone remodeling
US20060193916A1 (en) * 2005-01-07 2006-08-31 Acologix, Inc. Formulations of peptides for periodontal and dental treatments
US7622438B1 (en) 2005-07-18 2009-11-24 Acologix, Inc. Protein formulation for promoting hard tissue formation
EP2061376A2 (de) * 2006-09-15 2009-05-27 Imaging Therapeutics, Inc. Verfahren und system zur bereitstellung einer bruch/nichtbruch-klassifizierung
DK2117578T3 (en) * 2007-01-22 2015-07-20 Orthotrophix Inc Peptide composition and method for promoting cartilage formation
US8939917B2 (en) 2009-02-13 2015-01-27 Imatx, Inc. Methods and devices for quantitative analysis of bone and cartilage
TWI382852B (zh) * 2009-12-22 2013-01-21 Univ Taipei Medical 一種口腔保健用磷酸鈣複合物及其製法與組合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015A (en) * 1847-03-13 Mode of producing reciprocating and latkral motions
CA1315480C (en) * 1986-06-12 1993-03-30 Eric Charles Reynolds Phosphopeptides
US5015628A (en) * 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
JPH01285158A (ja) * 1988-05-12 1989-11-16 Itochu Shiryo Kk 家禽用飼料
US5051401A (en) * 1989-04-07 1991-09-24 University Of South Alabama Inhibition of mineral deposition by phosphorylated and related polyanionic peptides
US5837674A (en) * 1996-07-03 1998-11-17 Big Bear Bio, Inc. Phosphopeptides and methods of treating bone diseases

Also Published As

Publication number Publication date
US5837674A (en) 1998-11-17
EP0938326A1 (de) 1999-09-01
WO1998000156A1 (en) 1998-01-08
CA2258661A1 (en) 1998-01-08
EP0938326A4 (de) 2002-07-03
US6306822B1 (en) 2001-10-23
JP2001503452A (ja) 2001-03-13
PT938326E (pt) 2004-11-30
CA2258661C (en) 2002-09-10
AU3587197A (en) 1998-01-21
ATE275961T1 (de) 2004-10-15
AU727675B2 (en) 2000-12-21
EP0938326B1 (de) 2004-09-15
DE69730725T2 (de) 2006-02-23
ES2224260T3 (es) 2005-03-01
JP2004067687A (ja) 2004-03-04
DK0938326T3 (da) 2005-01-03

Similar Documents

Publication Publication Date Title
DE69730725D1 (de) Synthetische phosphopeptide zur behandlung von knochenerkrankheiten
DE69736183D1 (de) Verwendung von topiramat oder derivate davon zur herstellung eines arzneimittels zur behandlung von manisch-depressiven bipolaren störungen
ATE302599T1 (de) Zubereitungen und verfahren zur behandlung oder prävention von krankheiten der körperpassagewege
ATE271393T1 (de) Zusammensetzungen zur erhöhung des hautdurchtritts von arzneistoffen unter verwendung von permeationsbeschleunigern
ATE275383T1 (de) Oxadisäuren und verwandte verbindungen zur behandlung von hautstörungen
ATE271038T1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
ATE185971T1 (de) Kombinationspräparat zur behandlung hypogonadaler männer sowie männern mit hypophysenerkrankungen
DE69328981D1 (de) Verfahren zur Behandlung von hyperproliferaktiven Gefässerkrankungen unter Verwendung von Rapamycin, eventuell in Kombination mit Mykophenolsäure
DE69934112D1 (de) Implantierbarer gewebeverschluss und system zur behandlung gastroösophagischen rückflusses
DE60137430D1 (de) Gewebeimplant zur wiederherstellung von knorpelgewebe
DE69022249T2 (de) Knochenwachsapplikator zur Behandlung von Knochengewebe.
DE29602789U1 (de) Liege, Decke o.dgl. zur therapeutischen Behandlung von Lebewesen
DE69929787D1 (de) Verfahren zur behandlung von neurologischen erkrankungen mit hilfe der bestimmung des bche genotyps
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE69638281D1 (de) Anti-Interleukin-9 Antikörper oder Anti-Interleukin-9 Rezeptor Antikörper zur Behandlung von bronchialem Hyperreaktionsvermögen
DE69314234D1 (de) Konservierte Polysiloxanemulsion zur Behandlung von Geweben
DE69910202D1 (de) EGR-1 zur Herstellung eines Medikamentes zur Behandlung von Wunden
DE69943089D1 (de) Methode zur behandlung von staphylokokkeninfektionen
DE69737067D1 (de) Vakzine zur behandlung von mycosen
DE69805305D1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
ATE226071T1 (de) Antikonvulsive derivate zur behandlung von neuropathischem schmerz
DE69607559T2 (de) Verfahren zur Behandlung von Phenolteer
DE69301750T2 (de) Verwendung von 1-Alpha,24(R)-Dihydroxy-22(E)-Dehydrovitamin-D3 zur Herstellung eines Arzneimittels zur Behandlung der Osteoporose
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE69918145D1 (de) Verwendung von diltiazem zur behandlung von pathologien der netzhaut

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee